Resveratrol Protects Against Pathological Preterm Birth by Suppression of Macrophage-Mediated Inflammation. (December 2015)

• Record Type: Journal Article
• Authors: Furuya, Hitomi; Taguchi, Ayumi; Kawana, Kei; Yamashita, Aki; Inoue, Eri; Yoshida, Mitsuyo; Nakamura, Hiroe; Fujimoto, Asaha; Inoue, Tomoko; Sato, Masakazu; Nishida, Haruka; Nagasaka, Kazunori; Adachi, Katsuyuki; Hoya, Mari; Nagamatsu, Takeshi; Wada-Hiraike, Osamu; Yamashita, Takahiro; Osuga, Yutaka; Fujii, Tomoyuki
• Is Part Of: Reproductive sciences. Volume 22:Number 12(2015:Dec.)
• Page Start: 1561
• Page End: 1568
• Publication Date: 2015-12
• Subjects: resveratrol -- LPS-induced preterm birth -- peritoneal macrophage -- anti-inflammatory effect -- COX-2; Reproductive health -- Periodicals; Reproduction -- Periodicals; 612.6
• DOI: 10.1177/1933719115589413
• Languages: English
• ISSNs: 1933-7191

Abstract

Inflammatory cytokines play a major role in spontaneous preterm birth. Resveratrol has strong anti-inflammatory effects, but its effect on preterm birth in vivo is unknown. We investigated whether resveratrol protects against preterm birth in the lipopolysaccharide (LPS)-induced preterm mouse model. Twelve-day-old pregnant mice were fed 20 to 40 mg/kg resveratrol daily. On day 15, 10 μg of LPS was injected into uterine cervices. Resveratrol administration significantly decreased the rate of preterm birth. Resveratrol administration abolished LPS-induced elevation of tumor necrosis factor α (TNF-α) and interleukin (IL) 1β but not IL-6 levels. The TNF-α messenger RNA levels were decreased in the cervices of resveratrol-administered mice compared with controls. Resveratrol treatment suppressed the elevation in TNF-α and IL-1β levels in LPS-exposed peritoneal macrophages. Further resveratrol treatment eradicated the proinflammatory cytokine-mediated elevation in cyclooxygenase 2 (COX-2) in peritoneal macrophages. Resveratrol may protect against pathological preterm birth by suppression of elevated proinflammatory cytokines and consequent elevation of COX-2 in macrophages.